Dr. Stephen E. Hohmann, MD
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- University of California, San Diego School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 403
Licensed in Texas since 2004, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of California, San Diego School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
TX license M0112 (first issued 2004; active) -
Specialist
TX license M0112 (first issued 2004; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor University Medical Center Dallas, TX
- Baylor Scott & White Medical Center- Waxahachie Waxahachie, TX
- Baylor Scott & White Heart & Vascular Hospital - Dallas Dallas, TX
- Methodist Mansfield Medical Center Mansfield, TX
- Methodist Dallas Medical Center Dallas, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 403
- Services billed
- 1,106
- Patients’ average age
- 68
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 30-44 minutes | 112 | 112 |
| Established patient office or other outpatient visit, 20-29 minutes | 95 | 82 |
| Established patient office or other outpatient visit, 30-39 minutes | 93 | 83 |
| Ultrasound of hemodialysis access | 69 | 57 |
| Ultrasonic guidance for blood vessel access | 51 | 42 |
| Ultrasound study of arm and leg arteries | 45 | 42 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 38 | 37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | 30 |
| Creation of artery-vein connection using tube graft for hemodialysis | 31 | 31 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 30 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Dallas, TX | 53 |
| Tramadol Hcl Other prescribers in Dallas, TX | 39 |
| Eliquis (apixaban) Other prescribers in Dallas, TX | 37 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Dallas, TX | 15 |
| Acetaminophen-Codeine (acetaminophen with codeine) Other prescribers in Dallas, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 68 payments worth $34,330 in total to this clinician.
| Merit Medical Systems Inc | $18,372 |
|---|---|
| Bard Peripheral Vascular, Inc. | $10,572 |
| W. L. Gore & Associates, Inc. | $3,056 |
| Mozarc Medical US LLC | $1,010 |
| Axogen | $346 |
| Sonavex, Inc. | $207 |
| Imperative Care, Inc | $206 |
| Bolton Medical Inc | $198 |
| Speaking at a medical education program | $16,900 |
|---|---|
| Consulting Fee | $15,578 |
| Food and Beverage | $1,685 |
| Travel and Lodging | $167 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merit Medical Systems Inc May 14, 2025 | Speaking at a medical education program | $6,800 |
| Merit Medical Systems Inc Aug 20, 2025 | Speaking at a medical education program | $5,600 |
| Merit Medical Systems Inc Mar 5, 2025 | Speaking at a medical education program Wrapsody Stent Graft · Vascular Surgery | $4,500 |
| Bard Peripheral Vascular, Inc. Jun 23, 2025 | Consulting Fee | $2,500 |
| W. L. Gore & Associates, Inc. Mar 11, 2025 | Consulting Fee GORE VIABAHN Endoprosthesis with Heparin; VIABAHN Endoprosthesis with PROPATEN Bioactive Surface; GORE PROPATEN Vascular Graft · Devices | $2,200 |
| Bard Peripheral Vascular, Inc. Mar 3, 2025 | Consulting Fee | $1,725 |
| Bard Peripheral Vascular, Inc. Sep 15, 2025 | Consulting Fee | $1,563 |
| Bard Peripheral Vascular, Inc. Nov 24, 2025 | Consulting Fee | $1,563 |
| Bard Peripheral Vascular, Inc. Apr 28, 2025 | Consulting Fee | $1,438 |
| Bard Peripheral Vascular, Inc. May 27, 2025 | Consulting Fee | $1,438 |
All 17 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. Nov 24, 2025 | Consulting Fee | $1,563 |
| Bard Peripheral Vascular, Inc. Sep 15, 2025 | Consulting Fee | $1,563 |
| Merit Medical Systems Inc Aug 20, 2025 | Speaking at a medical education program | $5,600 |
| Merit Medical Systems Inc Aug 20, 2025 | Consulting Fee | $1,306 |
| Mozarc Medical US LLC Jul 8, 2025 | Consulting Fee PALINDROME · DIALYSIS CATHETERS | $450 |
| Bard Peripheral Vascular, Inc. Jun 23, 2025 | Consulting Fee | $2,500 |
| Bard Peripheral Vascular, Inc. May 27, 2025 | Consulting Fee | $1,438 |
| Merit Medical Systems Inc May 14, 2025 | Speaking at a medical education program | $6,800 |
| Merit Medical Systems Inc May 14, 2025 | Travel and Lodging travel to Dallas, TX | $97.43 |
| Merit Medical Systems Inc May 14, 2025 | Travel and Lodging travel to Tampa, FL | $69.16 |
| Bard Peripheral Vascular, Inc. Apr 28, 2025 | Consulting Fee | $1,438 |
| Bard Peripheral Vascular, Inc. Apr 24, 2025 | Consulting Fee | $288 |
| Mozarc Medical US LLC Apr 9, 2025 | Consulting Fee PALINDROME · DIALYSIS CATHETERS | $450 |
| W. L. Gore & Associates, Inc. Mar 11, 2025 | Consulting Fee GORE VIABAHN Endoprosthesis with Heparin; VIABAHN Endoprosthesis with PROPATEN Bioactive Surface; GORE PROPATEN Vascular Graft · Devices | $2,200 |
| W. L. Gore & Associates, Inc. Mar 11, 2025 | Consulting Fee GORE VIABAHN Endoprosthesis with Heparin; VIABAHN Endoprosthesis with PROPATEN Bioactive Surface; GORE PROPATEN Vascular Graft · Devices | $660 |
| Merit Medical Systems Inc Mar 5, 2025 | Speaking at a medical education program Wrapsody Stent Graft · Vascular Surgery | $4,500 |
| Bard Peripheral Vascular, Inc. Mar 3, 2025 | Consulting Fee | $1,725 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $23,068 in research payments for these studies, mostly to the institutions running them.
- PReSeRVE-HD: Observational Study of the Merit HeRO Graft and Super HeRO in Patients on Hemodialysis
Merit Medical Systems Inc - The Merit Wrapsody AV Access Efficacy Study
Merit Medical Systems Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.